American Society Of Clinical Oncology
American Society of Clinical Oncology shows consistent revenue growth and strong asset accumulation over the past decade.
EIN: 136180380 · Alexandria, VA · NTEE: G9XC · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $177.2M |
| Total Expenses | $155.5M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $177M |
| Net Assets | $183.8M |
| Transparency Score | 85/100 |
Is American Society Of Clinical Oncology Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American Society Of Clinical Oncology directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American Society Of Clinical Oncology
American Society Of Clinical Oncology (EIN: 136180380) is a nonprofit organization based in Alexandria, VA, classified under NTEE code G9XC. The organization reported total revenue of $177.2M and total assets of $321.7M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Society Of Clinical Oncology's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Society Of Clinical Oncology is a major nonprofit that has been operating for 61 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 6.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $174.3M |
| Total Expenses | $155.5M |
| Surplus / Deficit | +$18.8M |
| Total Assets | $296.5M |
| Total Liabilities | $112.7M |
| Net Assets | $183.8M |
| Operating Margin | 10.8% |
| Debt-to-Asset Ratio | 38.0% |
| Months of Reserves | 22.9 months |
Financial Health Grade: A
In 2023, American Society Of Clinical Oncology reported a surplus of $18.8M with revenue exceeding expenses, holds 22.9 months of operating reserves (strong position), has a debt-to-asset ratio of 38.0% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), American Society Of Clinical Oncology's revenue has grown at a compound annual growth rate (CAGR) of 6.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +19.3% | +7.8% | +17.9% |
| 2022 | +35.8% | +20.4% | -11.4% |
| 2021 | -22.2% | -11.1% | +1.6% |
| 2020 | -15.0% | -9.0% | +3.6% |
| 2019 | +1.8% | +1.6% | +18.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2800 |
| IRS Ruling Date | 1965 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Society Of Clinical Oncology with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, American Society Of Clinical Oncology allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $18.8M, with revenue exceeding expenses.
- Debt-to-asset ratio: 38.0%.
Executive Compensation Analysis
The reported 0% officer compensation across all filings is unusual for an organization of ASCO's size and revenue ($177M latest revenue), suggesting executive compensation may be categorized differently or not reported under this specific line item on the 990.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of American Society Of Clinical Oncology's IRS 990 filings:
- Unusual 0% officer compensation reported across all filings, warranting further investigation into executive pay structures.
Strengths
The following positive indicators were identified for American Society Of Clinical Oncology:
- Consistent revenue growth, from $101.9M in 2014 to $174.3M in 2023.
- Strong asset accumulation, with assets growing from $217.5M in 2014 to $296.5M in 2023.
- Generally operates with a financial surplus, indicating sound financial management.
- Healthy balance sheet with assets significantly exceeding liabilities (e.g., $296.5M assets vs. $112.7M liabilities in 2023).
Frequently Asked Questions about American Society Of Clinical Oncology
Is American Society Of Clinical Oncology a legitimate charity?
American Society Of Clinical Oncology (EIN: 136180380) is a registered tax-exempt nonprofit based in Virginia. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $177.2M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does American Society Of Clinical Oncology spend its money?
American Society Of Clinical Oncology directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to American Society Of Clinical Oncology tax-deductible?
American Society Of Clinical Oncology is registered as a tax-exempt nonprofit (EIN: 136180380). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the American Society Of Clinical Oncology CEO make?
American Society Of Clinical Oncology's highest-compensated officer earns $177M annually. The organization reported $177.2M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of American Society Of Clinical Oncology's spending goes to programs?
American Society Of Clinical Oncology directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does American Society Of Clinical Oncology compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), American Society Of Clinical Oncology is above average for NTEE category G9XC nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American Society Of Clinical Oncology located?
American Society Of Clinical Oncology is headquartered in Alexandria, Virginia and files with the IRS under EIN 136180380. It is classified under NTEE code G9XC.
How many years of IRS 990 filings does American Society Of Clinical Oncology have?
American Society Of Clinical Oncology has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $177.2M in total revenue.
Is American Society Of Clinical Oncology a good charity?
Based on its strong financial health, consistent growth in revenue and assets, and generally positive net income, ASCO appears to be a well-managed organization. Its mission focus on clinical oncology, combined with its financial stability, suggests it is an effective entity in its field.
How has ASCO's financial position changed over the last decade?
ASCO has significantly strengthened its financial position over the last decade. Revenue increased from $101,928,641 in 2014 to $174,337,293 in 2023, and assets grew from $217,539,280 to $296,538,439 in the same period, demonstrating substantial growth and stability.
What is the trend in ASCO's expenses relative to its revenue?
ASCO generally maintains expenses below revenue, leading to consistent surpluses. For example, in 2023, expenses were $155,488,043 against revenue of $174,337,293. There was an exception in 2021 where expenses ($119,778,637) slightly exceeded revenue ($107,588,628).
Filing History
IRS 990 filing history for American Society Of Clinical Oncology showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), American Society Of Clinical Oncology's revenue has grown by 109.7%, moving from $83.1M to $174.3M. Total assets increased by 82.6% over the same period, from $162.4M to $296.5M. Total functional expenses rose by 114.9%, from $72.4M to $155.5M. In its most recent filing year (2023), American Society Of Clinical Oncology reported a surplus of $18.8M, with revenue exceeding expenses. The organization holds $112.7M in liabilities against $296.5M in assets (debt-to-asset ratio: 38.0%), resulting in net assets of $183.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $174.3M | $155.5M | $296.5M | $112.7M | — | View 990 |
| 2022 | $146.1M | $144.3M | $251.5M | $107.1M | — | View 990 |
| 2021 | $107.6M | $119.8M | $283.8M | $114.6M | — | View 990 |
| 2020 | $138.4M | $134.7M | $279.2M | $119.3M | — | View 990 |
| 2019 | $162.7M | $148.1M | $269.5M | $131.9M | — | View 990 |
| 2018 | $159.9M | $145.8M | $227.7M | $118.6M | — | View 990 |
| 2017 | $144.5M | $136.6M | $228.3M | $117.4M | — | View 990 |
| 2016 | $114.8M | $116.9M | $213.0M | $111.1M | — | View 990 |
| 2015 | $107.4M | $106.8M | $209.3M | $110.2M | — | View 990 |
| 2014 | $101.9M | $88.1M | $217.5M | $112.8M | — | View 990 |
| 2013 | $93.0M | $79.8M | $195.6M | $98.3M | — | View 990 |
| 2012 | $88.4M | $78.1M | $177.2M | $104.5M | — | View 990 |
| 2011 | $83.1M | $72.4M | $162.4M | $103.7M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $174.3M, expenses of $155.5M, and assets of $296.5M (revenue +19.3% year-over-year).
- 2022: Revenue of $146.1M, expenses of $144.3M, and assets of $251.5M (revenue +35.8% year-over-year).
- 2021: Revenue of $107.6M, expenses of $119.8M, and assets of $283.8M (revenue -22.2% year-over-year).
- 2020: Revenue of $138.4M, expenses of $134.7M, and assets of $279.2M (revenue -15.0% year-over-year).
- 2019: Revenue of $162.7M, expenses of $148.1M, and assets of $269.5M (revenue +1.8% year-over-year).
- 2018: Revenue of $159.9M, expenses of $145.8M, and assets of $227.7M (revenue +10.6% year-over-year).
- 2017: Revenue of $144.5M, expenses of $136.6M, and assets of $228.3M (revenue +25.9% year-over-year).
- 2016: Revenue of $114.8M, expenses of $116.9M, and assets of $213.0M (revenue +6.9% year-over-year).
- 2015: Revenue of $107.4M, expenses of $106.8M, and assets of $209.3M (revenue +5.3% year-over-year).
- 2014: Revenue of $101.9M, expenses of $88.1M, and assets of $217.5M (revenue +9.6% year-over-year).
- 2013: Revenue of $93.0M, expenses of $79.8M, and assets of $195.6M (revenue +5.2% year-over-year).
- 2012: Revenue of $88.4M, expenses of $78.1M, and assets of $177.2M (revenue +6.4% year-over-year).
- 2011: Revenue of $83.1M, expenses of $72.4M, and assets of $162.4M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Society Of Clinical Oncology:
Data Sources and Methodology
This transparency report for American Society Of Clinical Oncology is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.